Investor's Business Daily on MSN
Novo Sweetens Its Bid For Metsera As Takeover Drama With Pfizer Escalates
Novo Nordisk said it would pay up to $10 billion to acquire obesity-focused Metsera, topping Pfizer's recently hiked $8.1 ...
(Reuters) -Eli Lilly and Novo Nordisk plan to announce new drug pricing deals with the White House, including for their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback